Question · asked by 1 review
Erythropoietin vs placebo: Death
- Population
- patients with anemia in people with AIDS
- Intervention
- Erythropoietin
- Comparison
- placebo
- Outcome
- Death
It is very uncertain whether recombinant Human Erythropoietin changes death compared with placebo (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Recombinant Human Erythropoietin vs Placebo Death · patients with anemia in people with AIDS It is very uncertain whether recombinant Human Erythropoietin changes death compared with placebo (very low certainty). Treatment for anemia in people with AIDS (2011) · Cochrane Headline outcomes only | RR 0.56 [0.08, 4.05] | 2 studies · 84 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Treatment for anemia in people with AIDS 2011 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.